Practice Issues: Genetic test predicts tamoxifen response Paroxetine cuts tamoxifen effectiveness in breast cancerOntario study links the drug combo with increased mortality Prostate biopsy complication rate rising Canadian data reveal most hospital admissions for these adverse events are due to infections Antibody shows promise against bone tumour Trial drug overcomes resistant chronic myeloid leukemia Omacetaxine battles genetic mutation that negates existing therapy Chemo- trastuzumab combo ups survival Wait times for diagnosis exceed accepted targets Adjuvant therapy has feverish results in real-world care Febrile neutropenia observed at higher than expected rate Nilotinib bests imatinib in chronic myeloid leukemia Questions about tolerability and cost of treatment need answering before clinical practice should change Study OKs dose boost for estrogen receptor antagonist First Previous 67 68 69 70 71 Next Last
